Claritev Corporation

Claritev Corporation (NYSE:CTEV) is a healthcare technology and data analytics company that provides cost management and payment integrity solutions to the U.S. healthcare industry. Founded in 1980 and originally known as MultiPlan Corporation, the company rebranded to Claritev in February 2025 as part of its strategic transformation initiative called "Vision 2030." Headquartered in New York, the company went public in April 2020 and has evolved from a traditional healthcare cost containment provider into a data-driven technology company focused on reducing healthcare costs through advanced analytics and network-based solutions.

Over the past few years, Claritev has undergone significant strategic transformation in response to declining traditional revenue streams and evolving healthcare market dynamics. The most visible change was the company's rebranding from MultiPlan Corporation to Claritev Corporation in February 2025, symbolizing its shift from a traditional healthcare cost containment company to a technology and data-focused organization. The centerpiece of this transformation is the Vision 2030 strategic initiative, launched to modernize the company's operations and reduce operating costs by 10-15%. This comprehensive program includes implementing Oracle Cloud-based systems, developing cloud-native products, and establishing a new enterprise resource planning (ERP) system. The company hired its first Chief AI Officer and is investing heavily in artificial intelligence capabilities to enhance its analytics offerings. Product innovation has accelerated with the launch of CompleteVue, a transparency analytics product designed to help clients navigate the complex landscape of healthcare price transparency regulations. The company identified 15 new product ideas and 30 enhancements in 2024, focusing on expanding beyond traditional cost containment into broader healthcare insights and decision support tools. Operational restructuring includes implementing a general manager model to streamline business operations and improve accountability. The company is pursuing new market opportunities in federal government contracts and specialty network services while strengthening relationships with existing clients through enhanced service offerings. Despite these initiatives, the company faces ongoing challenges with revenue retention, projecting a 97% net revenue retention rate for 2025. The network-based services segment, historically the largest revenue contributor, continues to decline as healthcare market dynamics shift toward direct contracting and price transparency requirements. The strategic focus has shifted toward developing predictable, multi-year revenue models and expanding into adjacent healthcare technology markets, though commercial traction for new products has been slower than anticipated.